Acute drug-induced spine changes in the nucleus accumbens are dependent on β-adducin

Neuropharmacology. 2016 Nov;110(Pt A):333-342. doi: 10.1016/j.neuropharm.2016.07.035. Epub 2016 Jul 29.

Abstract

Chronic modifications of dopamine transmission alter striatal dendritic spines. Here, we show that spine density and length are increased in the nucleus accumbens 24 h after a single injection of caffeine or quinpirole, a dopamine D2/D3 dopamine receptors agonist, whereas the dopamine antagonist haloperidol has opposite effects. These effects are absent in mice lacking β-adducin, a protein that stabilizes actin/spectrin cortical cytoskeleton and modulates synaptic plasticity. Phosphorylation of adducin (Ser713 in β-adducin), which disrupts actin/spectrin interaction, is increased by quinpirole, haloperidol, or caffeine. We previously demonstrated that DARPP-32 interacts with β-adducin and facilitates its phosphorylation. Quinpirole increased DARPP-32 phosphorylation at Thr75 and haloperidol at Ser97, two modifications that can have similar consequences on adducin phosphorylation through distinct mechanisms. Experiments in DARPP-32 mutant mice confirmed that the apparently paradoxical similar effects of quinpirole and haloperidol on adducin phosphorylation may result from differential effects of these drugs on DARPP-32 phosphorylation at Thr75 and Ser97. Our data provide novel insights on how a single dose of widely used psychoactive drugs can affect spine plasticity in the nucleus accumbens, a component of the reward system.

Keywords: Antipsychotics; Caffeine; DARPP-32; Dendritic spines; Dopamine; Dopamine D2 receptors; Phosphorylation; Striatum.

MeSH terms

  • Animals
  • Caffeine / pharmacology
  • Cytoskeletal Proteins
  • Dendritic Spines / drug effects*
  • Dendritic Spines / metabolism*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / genetics
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Female
  • Haloperidol / pharmacology
  • Male
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Microfilament Proteins / metabolism*
  • Nucleus Accumbens / cytology
  • Nucleus Accumbens / drug effects*
  • Nucleus Accumbens / metabolism*
  • Phosphorylation / drug effects
  • Psychotropic Drugs / pharmacology*
  • Quinpirole / pharmacology

Substances

  • Add2 protein, mouse
  • Cytoskeletal Proteins
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Microfilament Proteins
  • Ppp1r1b protein, mouse
  • Psychotropic Drugs
  • Quinpirole
  • Caffeine
  • Haloperidol